Channel Management Director, SVC BP at GE Healthcare

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical TechnologyIndustries

Requirements

Bachelor’s degree or above, majoring in business, marketing, engineering or related are preferred
At least 8 years’ experience in MedTech industry
First-hand experience in sales or channel management is a must
Prior experience to drive complex project
Direct and indirect leadership experience
Dealer compliance management experience a plus
Strong executive presence with exceptional ability to present to C-suite level decision makers
Strong analytical skills with strategic thinking: ability to analyze complex data into strategic insights & initiatives, strong ability to present findings in a concise and simple manner
Interpersonal flexibility, tolerance and listening skills
Strong ethics and integrity and compliance orientation
Good at oral and written English

Responsibilities

Develop BU Channel strategy, lead market intelligence, performance tracking & review, project-based analysis for BU channel business
Work with the Business Head and Sales leaders to define appropriate coverage models for dedicated business. Identify national and regional wised channel competitive landscape
Cultivating long-term relationships with strategic channel partners to support business growth
Provide guidance for BU channel development and dealer deployment, define dealer profile, selection criteria, and entry threshold etc
Design and continuously optimize BU channel incentive plan and other policies and processes for critical channel management activities such as performance management, grading evaluation, sub dealer management, market promotion, and conflict management etc
Lead training design, compile training demand (from Sales, modality, regional channel team), drive task assignment
Verify OP and territory assignment for dedicated BU
Track core dealers' and new dealers' performance & take actions
Create a culture of highest integrity and compliance within channels
Adhere to and uphold highest standards of compliance to relevant international and local Regulatory and GE Healthcare Promotional Codes
Adhere to GE and GE Healthcare compliance policies, codes and training requirements

Skills

Channel Strategy

Market Intelligence

Performance Tracking

Strategic Partnerships

Dealer Management

Incentive Design

Compliance Management

Training Design

Sales Leadership

Business Optimization

GE Healthcare

Healthcare technology and data analytics provider

About GE Healthcare

GE Healthcare provides a range of healthcare technologies and services aimed at improving patient care. Its main products include imaging systems, mobile diagnostic devices, patient monitoring solutions, and advanced software for data analysis. These products help medical professionals make informed decisions and enhance the efficiency of healthcare delivery. Unlike many competitors, GE Healthcare invests significantly in research and development, allocating $1 billion each year to innovate and enhance its offerings. The company’s goal is to support healthcare providers in delivering better patient outcomes, as evidenced by its technology supporting over 300,000 patients daily and managing 2 billion patient scans each year.

Chicago, IllinoisHeadquarters

1892Year Founded

N/ACompany Stage

Data & Analytics, HealthcareIndustries

10,001+Employees

Risks

Emerging AR technologies increase competition in medical imaging.

Regulatory challenges may delay AI application expansions in healthcare.

Dependence on clinical trial success for new product market positioning.

Differentiation

GE Healthcare invests $1 billion annually in R&D for product innovation.

The company supports over 300,000 patients daily with its healthcare technologies.

GE Healthcare's AIR Recon DL offers 3D motion-insensitive imaging for enhanced MRI quality.

Upsides

Acquisition of Caption Health expands AI-powered ultrasound capabilities.

Successful Phase III trial of [18F]flurpiridaz enhances coronary artery disease detection.

Collaboration with Wayra accelerates digital health innovation in EMEA.

Land your dream remote job 3x faster with AI

Try Jobo Free